Gateway Investment Advisers LLC reduced its stake in Mylan NV (NASDAQ:MYL) by 4.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,463 shares of the company’s stock after selling 818 shares during the quarter. Gateway Investment Advisers LLC’s holdings in Mylan were worth $371,000 at the end of the most recent reporting period.
A number of other institutional investors also recently added to or reduced their stakes in the business. Vicus Capital increased its holdings in shares of Mylan by 5.3% during the first quarter. Vicus Capital now owns 7,874 shares of the company’s stock worth $223,000 after purchasing an additional 396 shares during the period. Pinnacle Bank increased its holdings in shares of Mylan by 66.4% during the first quarter. Pinnacle Bank now owns 1,060 shares of the company’s stock worth $30,000 after purchasing an additional 423 shares during the period. Global Retirement Partners LLC increased its holdings in shares of Mylan by 107.1% during the first quarter. Global Retirement Partners LLC now owns 967 shares of the company’s stock worth $27,000 after purchasing an additional 500 shares during the period. Securian Asset Management Inc increased its holdings in shares of Mylan by 1.0% during the first quarter. Securian Asset Management Inc now owns 52,672 shares of the company’s stock worth $1,493,000 after purchasing an additional 529 shares during the period. Finally, Piedmont Investment Advisors Inc. increased its holdings in shares of Mylan by 8.7% during the first quarter. Piedmont Investment Advisors Inc. now owns 8,335 shares of the company’s stock worth $236,000 after purchasing an additional 670 shares during the period. 83.76% of the stock is currently owned by hedge funds and other institutional investors.
Mylan stock traded up $0.26 during mid-day trading on Tuesday, reaching $18.31. The company had a trading volume of 443,293 shares, compared to its average volume of 5,758,533. Mylan NV has a fifty-two week low of $16.63 and a fifty-two week high of $39.59. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.85 and a current ratio of 1.51. The firm has a market cap of $9.30 billion, a P/E ratio of 4.01, a P/E/G ratio of 0.94 and a beta of 1.76. The company has a fifty day moving average of $18.35.
Several brokerages have recently commented on MYL. Royal Bank of Canada cut shares of Zayo Group from an “outperform” rating to a “sector perform” rating and raised their target price for the stock from $33.00 to $35.00 in a report on Wednesday, May 8th. Wells Fargo & Co cut shares of Mylan from an “outperform” rating to a “market perform” rating and lowered their target price for the stock from $33.00 to $22.00 in a report on Tuesday, May 7th. Zacks Investment Research cut shares of German American Bancorp. from a “buy” rating to a “hold” rating in a report on Tuesday, April 30th. Argus lowered their target price on shares of Mylan to $32.00 and set a “buy” rating on the stock in a report on Wednesday, March 27th. Finally, BMO Capital Markets cut shares of Capital Power from an “outperform” rating to a “market perform” rating in a report on Wednesday, May 8th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have issued a buy rating to the stock. Mylan presently has a consensus rating of “Buy” and a consensus price target of $33.65.
Mylan Company Profile
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally. It offers active pharmaceutical ingredients and finished dosage forms; and antiretroviral medicines to treat HIV/AIDS.
Recommended Story: What is the LIBOR?
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan NV (NASDAQ:MYL).
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.